The effects of the instantaneous scanning glucose monitoring system on hypoglycemia, weight gain, and health behaviors in patients with gestational diabetes: a randomised trial.

Abstract

Gestational diabetes (GDM) can cause adverse effects on parturient and newborns, and effective control of blood sugar levels in the parturient is essential for good prognosis. Continuous dynamic blood glucose monitoring can effectively improve the final pregnancy outcome of patients with GDM. A total of 110 GDM patients admitted to our hospital from April 2019 to April 2020 were selected and divided into 2 groups according to the random number table method, with 55 participants in each group. In the control group, fingertip blood glucose monitoring was used, and in the ISGMS group the ISGMS was used in combination with fingertip blood glucose monitoring. The incidence of hypoglycemia, the qualified rate of weight gain at the end of pregnancy, compliance with blood glucose monitoring, and health behavior patterns were compared between the 2 groups. Patients who used the ISGSM showed a lower incidence of hypoglycemia (P<0.05), a greater qualified rate of weight gain at the end of pregnancy (P<0.05), had higher blood glucose monitoring compliance (P<0.05), and demonstrated better health behaviors (P<0.05) compared to the control group after 2 weeks of intervention. The application of the ISGMS in patients with GDM improved the compliance of blood glucose monitoring, improved health behaviors, reasonably controlled weight gain, and avoided hypoglycemia. Chinese Clinical Trial Registry ChiCTR2100045927.